NewsBenzingaMorgan Stanley Maintains Underweight on Lazard, Lowers Price Target to $41 Morgan Stanley Maintains Underweight on Lazard, Lowers Price Target to $41 Benzinga 2026.10.08 14:21 (GMT+0) Open on Benzinga Other news Barclays Maintains Overweight on Jackson Financial, Raises Price Target to $151 Innospec Q2 2026 Earnings Call: Complete Transcript Barclays Maintains Equal-Weight on Clean Harbors, Raises Price Target to $335 Why Is Unity Software Stock Gaining Thursday? Full Transcript: Hagerty Q2 2026 Earnings Call Barclays Maintains Equal-Weight on Blackstone, Lowers Price Target to $124
